Healthcare / Medical Care FacilitiesNasdaqCM
$0.95
+0.04 (+4.40%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 20%
FCF escenarios
weak_data · normalized FCF $-8.3M · quality 52.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
42/100
C
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$3M
P/E
0.0x
↓EV/EBITDA
0.4x
↓ROE
37.1%
↑Gross Margin
20.2%
↓Debt/Equity
0.18
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-7.4%
FCF CAGR
—
FCF margin
-352.8%
FCF / Net income
-1.69x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $4.7M · net income $9.9M · FCF $-16.7M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $4.7M | $4.7M | $5.4M | $5.1M | $5.9M |
| Net Income | $9.9M | $9.9M | $-524643.00 | $130193.00 | $458667.00 |
| EBITDA | $10.8M | $10.8M | $24113.00 | $384305.00 | $725689.00 |
| EPS | 36.48 | 36.48 | -1384.28 | 770.37 | 2714.01 |
| Gross Margin | 20.2% | 20.2% | 33.6% | 32.7% | 25.9% |
| Operating Margin | -226.9% | -226.9% | -21.4% | 0.8% | 6.7% |
| Net Margin | 209.0% | 209.0% | -9.7% | 2.5% | 7.7% |
| Balance Sheet | |||||
| Debt/Equity | 0.18 | 0.18 | -2.89 | 0.09 | 0.80 |
| Current Ratio | 3.12 | 3.12 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-16.7M | $-16.7M | $-8.3M | $-1.8M | $1.6M |
| Returns | |||||
| ROE | 37.1% | 37.1% | 50.0% | 3.5% | 81.5% |
| Valuation | |||||
| P/E | 0.03 | 0.03 | — | 42.45 | 11.27 |
| EV/EBITDA | 0.40 | 0.40 | 125.35 | 15.10 | 7.71 |
| P/B | 0.01 | 0.01 | — | 1.48 | 9.18 |
| Growth & Yield | |||||
| Revenue Growth | -13.0% | -13.0% | 5.8% | -13.6% | — |
| EPS Growth | 102.6% | 102.6% | -279.7% | -71.6% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-86.8%
EPS terminal req.
$0.08
Spread vs growth
189.4%
5Y implied EPS CAGR
-69.1%
EPS terminal req.
$0.10
Spread vs growth
171.8%
10Y implied EPS CAGR
-41.7%
EPS terminal req.
$0.16
Spread vs growth
144.4%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-99.8%
Start / end P/E
n/dx → n/dx
EPS bridge
-1384.28 → 36.48
Residual
-99.8%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.